Psychological treatment may reduce the need for healthcare in patients with Crohn's disease
✍ Scribed by Hans-Christian Deter; Wolfram Keller; Jörn von Wietersheim; Günther Jantschek; Rainer Duchmann; Martin Zeitz
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 149 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Fistulas are a common complication of crohn's disease (cd) and are difficult to treat effectively. this study aimed to assess the effects of fistula on annual costs of healthcare and resource utilization for patients with cd. ## Methods: A retrospective analysis, using the pharmetr
## Background: Natalizumab, a humanized monoclonal igg(4) antibody to alpha4 integrin, was investigated as a treatment of active crohn's disease (cd). the safety of natalizumab given in combination with infliximab has not previously been studied. ## Methods: Seventy-nine adult patients with activ
## Background: Crohn's disease (cd) of the pouch is one of the leading causes of pouch failure in patients with restorative proctocolectomy. risk factors for pouch failure in these patients are yet to be identified. the aim of the study was to assess risk factors associated with pouch failure in pa